Watch our webinar featuring Dr. Winslow on the future of UTI testing
Here’s the latest good and bad news about COVID-19 drugs
AACR22: A COVID-19 vaccine for people with B-cell deficiency
Acutis Names Abdel Halim, PharmD, MSc, PhD, DABCC, FAACC as Chief Scientific Officer
COVID vaccine plus infection can lead to months of immunity
Epigenetic convergence in the rising tide of opioid overdose deaths
Innovative diagnostic tools in development to combat rising antibiotic-resistant microbes
Omicron XE — The New COVID Variant
Urinary tract infections: 1/3 of all healthcare-related infections
Medication monitoring supports the Recovery Friendly Workplace Tax Credit
Acutis Reveal™ helps prevent the misuse of antibiotics that contribute to AMR
R&D of novel antibiotics needed to treat life-threatening infections as AMR increases
World Health Day: Health is a Human Right
Public Health Workforce: Essential to our Future
Antibiotic Resistance: 5 things to know
The risks of COVID-19 infection for unvaccinated pregnant women
Rhode Island rolls out a program for harm reduction centers to battle the drug epidemic
A resurgence of COVID-19 cases in Europe & China
Is "brain fog" a result of a faulty immune response to COVID-19 infection?
A steep rise in hospitalizations of children due to Omicron
COVID-19 pandemic prediction
COVID reinfections surge with Omicron
10 billion COVID-19 vaccinations delivered worldwide
Theories on the emergence of the Omicron Variant
Recurring urinary tract infections, Antibiotic Resistance, and Acutis Reveal™ UTI